In a turbulent market environment, Moderna Inc (BMV:MRNA). shares have touched a 52-week low, sinking to $30.7, with concerning financial metrics showing negative EBITDA of $2.36 billion and gross ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback